Protext Mobility

Protext Mobility EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Protext Mobility (TXTM) as of Oct 21, 2026 is -1,460.56. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -17,545.30 — a change of -91.68% (higher).

EV/FCF

-1,460.56

YoY

-91.68%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Protext Mobility is 2022 -1,460.56 . EV/FCF (Enterprise Value to Free Cash Flow) of Protext Mobility was 2021 -17,545.30 . It decreases by -91.68% higher compared to the previous year.

The Protext Mobility EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2015
-226.19 USD
Jan 1, 2016
-227.86 USD
Jan 1, 2017
-260.49 USD
Jan 1, 2018
-836.82 USD
Jan 1, 2019
23,579.37 USD
Jan 1, 2020
-17,545.30 USD
Jan 1, 2022
-1,460.56 USD
The Protext Mobility EV/FCF history
YEAREV/FCFYoY
-1,460.56-91.68%
-17,545.30-174.41%
23,579.37-2,917.73%
-836.82+221.25%
-260.49+14.32%
-227.86+0.74%
-226.19—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Protext Mobility Stock analysis

What does Protext Mobility do? ProText Mobility, Inc. develops pharmaceutical applications for botanical drugs using proprietary live plant extraction technology. The company focuses on research, testing, and development of highly bioavailable botanical products with all-natural ingredients for nutraceutical and pharmaceutical applications. Its subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc., which support its product development and market reach. The company generates revenue through the sale of pharmaceutical applications and botanical products developed via its proprietary technology. These products target nutraceutical and pharmaceutical markets, with subsidiaries operating in South Africa and cannabis-related research. The primary buyers are companies in the nutraceutical and pharmaceutical sectors seeking natural, highly bioavailable formulations. Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. contribute to the company's revenue streams by expanding its product portfolio and market presence. The firm's focus on all-natural ingredients and proprietary extraction methods differentiates its offerings in the nutraceutical and pharmaceutical industries. Protext Mobility is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Protext Mobility stock

EV/FCF (Enterprise Value to Free Cash Flow) of Protext Mobility is -1,460.56 in 2022.

EV/FCF (Enterprise Value to Free Cash Flow) of Protext Mobility changed from -17,545.30 to -1,460.56, representing a -91.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Protext Mobility since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Protext Mobility with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Protext Mobility

All Key Metrics — Protext Mobility